Semler Scientific, Inc.
SMLR
$28.12
$0.030.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -30.39% | -25.28% | -17.44% | -11.93% | -4.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -30.39% | -25.28% | -17.44% | -11.93% | -4.50% |
| Cost of Revenue | -13.00% | -0.80% | 5.59% | -4.48% | -5.95% |
| Gross Profit | -31.77% | -27.07% | -19.07% | -12.51% | -4.39% |
| SG&A Expenses | 4.20% | -9.11% | -20.43% | -16.69% | -13.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.04% | -7.75% | -17.22% | -15.26% | -13.33% |
| Operating Income | -78.64% | -51.86% | -17.80% | -5.96% | 13.18% |
| Income Before Tax | 138.28% | -237.66% | 98.68% | -28.21% | -18.03% |
| Income Tax Expenses | 160.51% | -237.09% | 98.58% | -61.01% | -43.01% |
| Earnings from Continuing Operations | 134.19% | -237.76% | 98.70% | -18.71% | -10.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 134.19% | -237.76% | 98.70% | -18.71% | -10.82% |
| EBIT | -78.64% | -51.86% | -17.80% | -5.96% | 13.18% |
| EBITDA | -78.12% | -51.42% | -17.64% | -5.76% | 13.04% |
| EPS Basic | 46.15% | -172.20% | 73.72% | -21.25% | -12.27% |
| Normalized Basic EPS | 121.43% | -88.14% | 50.10% | -21.74% | -5.21% |
| EPS Diluted | 19.83% | -193.77% | 87.09% | -18.39% | -9.77% |
| Normalized Diluted EPS | 109.90% | -95.83% | 61.23% | -18.23% | -2.15% |
| Average Basic Shares Outstanding | 33.05% | 16.58% | 7.37% | 3.25% | 2.17% |
| Average Diluted Shares Outstanding | 26.63% | 8.10% | 1.92% | -1.32% | -1.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |